(Q43980382)
Statements
1 reference
Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial (English)
1 reference
Bernard Escudier
1 reference
Sergio Bracarda
1 reference
Joaquim Bellmunt
1 reference
Bohuslav Melichar
1 reference
Sylvie Négrier
1 reference
Emilio Bajetta
1 reference
Alain Ravaud
1 reference
Vesna Sneller
1 reference
13 October 2010
1 reference
1 reference
107
1 reference
2
1 reference
214-219
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference